| Year |
Citation |
Score |
| 2020 |
Slagter AE, Sikorska K, Grootscholten C, van Laarhoven HWM, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, van de Velde CJH, van Grieken NCT, van Sandick JW, Jansen EPM, Verheij M, Cats A. Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial. Cancer Medicine. 9: 6609-6616. PMID 32735752 DOI: 10.1002/Cam4.3118 |
0.352 |
|
| 2020 |
Joode Kd, Dumoulin DW, Engelen V, Bloemendal HJ, Verheij M, Laarhoven HWMv, Dingemans IH, Dingemans AC, Veldt AAMvd. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective. European Journal of Cancer. 136: 132-139. PMID 32683273 DOI: 10.1016/J.Ejca.2020.06.019 |
0.319 |
|
| 2020 |
Zerp SF, Bibi Z, Verbrugge I, Voest EE, Verheij M. Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system. Clinical and Translational Radiation Oncology. 24: 1-9. PMID 32577539 DOI: 10.1016/J.Ctro.2020.05.012 |
0.358 |
|
| 2020 |
Levy A, Wagner AD, Chargari C, Moehler M, Verheij M, Durand-Labrunie J, Kissel M, Chirat E, Burtin P, Ducreux M, Boige V, Nilsson M, Boku N, Chau I, Deutsch E. Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position. European Journal of Cancer (Oxford, England : 1990). 135: 103-112. PMID 32563014 DOI: 10.1016/J.Ejca.2020.04.032 |
0.378 |
|
| 2020 |
van der Heijden M, Essers PBM, Verhagen CVM, Willems SM, Sanders J, de Roest RH, Vossen DM, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32413532 DOI: 10.1016/J.Radonc.2020.05.013 |
0.3 |
|
| 2020 |
Slagter AE, Tudela B, van Amelsfoort RM, Sikorska K, van Sandick JW, van de Velde CJH, van Grieken NCT, Lind P, Nordsmark M, Putter H, Hulshof MCCM, van Laarhoven HWM, Grootscholten C, Braak JPBM, Meershoek-Klein Kranenbarg E, ... ... Verheij M, et al. Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial. European Journal of Cancer (Oxford, England : 1990). 130: 146-154. PMID 32208351 DOI: 10.1016/J.Ejca.2020.02.008 |
0.317 |
|
| 2020 |
Essers PBM, van der Heijden M, Vossen D, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. International Journal of Cancer. 147: 1732-1739. PMID 32167160 DOI: 10.1002/Ijc.32962 |
0.38 |
|
| 2020 |
Kwint MH, Walraven I, Verheij M, Sonke JJ, Belderbos JSA, Janssen TM. The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 146: 52-57. PMID 32114266 DOI: 10.1016/J.Radonc.2020.02.006 |
0.508 |
|
| 2020 |
Koëter T, Elferink MA, Verhoeven RHA, Zimmerman DDE, Wasowicz DK, Verheij M, Wilt JHWd. Hospital variance in neoadjuvant rectal cancer treatment and the influence of a national guideline update: Results of a nationwide population-based study Radiotherapy and Oncology. 145: 162-171. PMID 32007760 DOI: 10.1016/J.Radonc.2019.12.020 |
0.323 |
|
| 2020 |
Leal A, van Grieken NCT, Palsgrove DN, Phallen J, Medina JE, Hruban C, Broeckaert MAM, Anagnostou V, Adleff V, Bruhm DC, Canzoniero JV, Fiksel J, Nordsmark M, Warmerdam FARM, Verheul HMW, ... ... Verheij M, et al. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. Nature Communications. 11: 525. PMID 31988276 DOI: 10.1038/S41467-020-14310-3 |
0.367 |
|
| 2020 |
Steur WD, Amelsfoort RV, Putter H, Hartgrink H, Sikorska K, Cats A, Grieken Nv, Kranenbarg EM, Sandick Jv, Lind P, Norsmark M, Verheij M, Vede Cvd. Patterns of recurrence in the CRITICS gastric cancer trial: results from intention-to-treat and per-protocol analyses Ejso. 46. DOI: 10.1016/J.Ejso.2019.11.465 |
0.342 |
|
| 2019 |
van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Frontiers in Oncology. 9: 1470. PMID 31998639 DOI: 10.3389/Fonc.2019.01470 |
0.315 |
|
| 2019 |
Jackson MR, Ashton M, Koessinger AL, Dick C, Verheij M, Chalmers AJ. Mesothelioma cells depend on the anti-apoptotic protein Bcl-xL for survival and are sensitized to ionizing radiation by BH3-mimetics. International Journal of Radiation Oncology, Biology, Physics. PMID 31786278 DOI: 10.1016/J.Ijrobp.2019.11.029 |
0.317 |
|
| 2019 |
Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, et al. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. European Journal of Cancer (Oxford, England : 1990). 122: 42-52. PMID 31614288 DOI: 10.1016/J.Ejca.2019.07.021 |
0.501 |
|
| 2019 |
Elbers JBW, Al-Mamgani A, Tesseslaar MET, van den Brekel MWM, Lange CAH, van der Wal JE, Verheij M, Zuur CL, de Boer JP. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31563412 DOI: 10.1016/J.Radonc.2019.08.007 |
0.326 |
|
| 2019 |
Haan Rd, Werkhoven Ev, Heuvel MMvd, Peulen HMU, Sonke GS, Elkhuizen P, Brekel MWMvd, Tesselaar MET, Vens C, Schellens JHM, Triest Bv, Verheij M. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib Bmc Cancer. 19: 901. PMID 31500595 DOI: 10.1186/S12885-019-6121-3 |
0.399 |
|
| 2019 |
Lambrecht ML, Eaton DJ, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW. Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 138: 106-113. PMID 31252291 DOI: 10.1016/J.Radonc.2019.06.008 |
0.468 |
|
| 2019 |
van Berlo D, Khmelinskii A, Gasparini A, Salguero FJ, Floot B, de Wit N, van de Ven M, Song JY, Coppes RP, Verheij M, Sonke JJ, Vens C. Micro cone beam computed tomography for sensitive assessment of radiation-induced late lung toxicity in preclinical models. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 138: 17-24. PMID 31146069 DOI: 10.1016/J.Radonc.2019.05.007 |
0.493 |
|
| 2019 |
Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, ... ... Verheij M, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. PMID 31142840 DOI: 10.1038/S41586-019-1272-6 |
0.324 |
|
| 2019 |
Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C. Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy. Cancers. 11. PMID 30934880 DOI: 10.3390/Cancers11040445 |
0.313 |
|
| 2019 |
Hamming-Vrieze O, Depauw N, Craft DL, Chan AW, Rasch CRN, Verheij M, Sonke JJ, Kooy HM. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients. Physics in Medicine and Biology. PMID 30921775 DOI: 10.1088/1361-6560/Ab1459 |
0.507 |
|
| 2019 |
Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, ... ... Verheij M, et al. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. European Journal of Cancer (Oxford, England : 1990). 112: 1-8. PMID 30878666 DOI: 10.1016/J.Ejca.2019.01.106 |
0.363 |
|
| 2019 |
Lambrecht M, Clementel E, Sonke JJ, Nestle U, Adebahr S, Guckenberger M, Andratschke N, Weber DC, Verheij M, Hurkmans CW. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 132: 63-69. PMID 30825971 DOI: 10.1016/J.Radonc.2018.10.025 |
0.517 |
|
| 2019 |
Vollenbrock SE, Voncken FEM, Dieren JMv, Lambregts DMJ, Maas M, Meijer GJ, Goense L, Mook S, Hartemink KJ, Snaebjornsson P, Beek LCt, Verheij M, Aleman BMP, Beets‐Tan RGH, Bartels‐Rutten A. Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer British Journal of Surgery. 106: 596-605. PMID 30802305 DOI: 10.1002/Bjs.11094 |
0.31 |
|
| 2019 |
Borggreve AS, Goense L, Brenkman HJF, Mook S, Meijer GJ, Wessels FJ, Verheij M, Jansen EPM, van Hillegersberg R, van Rossum PSN, Ruurda JP. Imaging strategies in the management of gastric cancer: current role and future potential of MRI. The British Journal of Radiology. 92: 20181044. PMID 30789792 DOI: 10.1259/Bjr.20181044 |
0.328 |
|
| 2019 |
Kroon P, Frijlink E, Iglesias-Guimarais V, Volkov A, van Buuren MM, Schumacher TN, Verheij M, Borst J, Verbrugge I. Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity. Cancer Immunology Research. 7: 670-682. PMID 30782666 DOI: 10.1158/2326-6066.Cir-18-0654 |
0.321 |
|
| 2019 |
Elbers JBW, Veldhuis LI, Bhairosing PA, Smeele LE, Jóźwiak K, van den Brekel MWM, Verheij M, Al-Mamgani A, Zuur CL. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. 276: 647-655. PMID 30673847 DOI: 10.1007/S00405-019-05292-0 |
0.306 |
|
| 2019 |
Graham Martínez C, Knijn N, Verheij M, Nagtegaal ID, van der Post RS. Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysis. Histopathology. 74: 809-816. PMID 30376189 DOI: 10.1111/His.13781 |
0.332 |
|
| 2019 |
Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, Verheij M, Remeijer P, Sonke JJ, van den Brekel M, Al-Mamgani A. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 130: 25-31. PMID 30005953 DOI: 10.1016/J.Radonc.2018.06.032 |
0.541 |
|
| 2019 |
Slagter AE, Tudela B, Amelsfoort Rv, Sikorska K, Sandick JWv, Velde CJHVD, Grieken NCTv, Lind PA, Nordsmark M, Putter H, Kranenbarg EM–K, Jansen EP, Cats A, Verheij M. A comparison of elderly versus nonelderly patients in the CRITICS gastric cancer trial. Journal of Clinical Oncology. 37: 81-81. DOI: 10.1200/Jco.2019.37.4_Suppl.81 |
0.33 |
|
| 2019 |
Haan Rd, Pluim D, Verwijs M, Sonke G, Heuvel Mvd, Triest Bv, Verheij M, Vens C. Abstract C009: Clinical pharmacokinetic and pharmacodynamic analyses support biological effectivity of the PARP inhibitor olaparib as radiosensitizer at low doses Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C009 |
0.366 |
|
| 2019 |
Borggreve A, Defize I, Meijer G, Laarhoven HV, Langendijk H, Mul V, Voncken F, Verheij M. EP-1392 Preoperative image-guided identification of response to nCRT in esophageal cancer (PRIDE study) Radiotherapy and Oncology. 133. DOI: 10.1016/S0167-8140(19)31812-2 |
0.307 |
|
| 2019 |
Amelsfoort RMv, Steur Wd, Sikorska K, Jansen EPM, Cats A, Grieken NCv, Boot H, Lind PA, Kranenbarg EM, Nordsmark M, Hartgrink H, Putter H, Trip AK, Sandick JW, Tinteren Hv, ... ... Verheij M, et al. Patterns of Recurrence in the Critics Gastric Cancer Trial: Results from Intention-to-Treat and per-Protocol Analyses International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.555 |
0.342 |
|
| 2019 |
Slagter AE, Tudela B, Amelsfoort RMv, Sikorska K, Sandick JW, Velde CJvd, Grieken NCv, Lind PA, Nordsmark M, Putter H, Laarhoven HWv, Grootscholten C, Kranenbarg EM, Jansen EPM, Cats A, ... Verheij M, et al. Perioperative Therapy with Postoperative Chemoradiotherapy in the Critics Gastric Cancer Trial: A Comparison of Elderly Versus Non-Elderly Patients International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2049 |
0.346 |
|
| 2019 |
Steur Wd, Claassen Y, Hartgrink H, Kranenbarg EMK, Sandick Jv, Braak J, Jansen E, Grieken Nv, Putter H, Boot H, Cats A, Sikorska K, Tinteren Hv, Verheij M, Velde Cvd. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer: per protocol analysis of the CRITICS trial Ejso. 45. DOI: 10.1016/J.Ejso.2018.10.077 |
0.346 |
|
| 2018 |
Lambrecht M, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW. Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours. Physics and Imaging in Radiation Oncology. 8: 57-62. PMID 33458418 DOI: 10.1016/J.Phro.2018.10.003 |
0.492 |
|
| 2018 |
Elbers JBW, Al-Mamgani A, van den Brekel MWM, Jóźwiak K, de Boer JP, Lohuis PJFM, Willems SM, Verheij M, Zuur CL. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599818818443. PMID 30526317 DOI: 10.1177/0194599818818443 |
0.302 |
|
| 2018 |
Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, et al. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study. Bmc Cancer. 18: 1006. PMID 30342494 DOI: 10.1186/S12885-018-4892-6 |
0.317 |
|
| 2018 |
Claassen YHM, Hartgrink HH, de Steur WO, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH. Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 30238171 DOI: 10.1007/S10120-018-0875-1 |
0.352 |
|
| 2018 |
Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, Los M, Beerepoot LV, Peters FPJ, Hospers GAP, van Etten B, ... ... Verheij M, et al. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. Bmc Cancer. 18: 877. PMID 30200910 DOI: 10.1186/S12885-018-4770-2 |
0.36 |
|
| 2018 |
Huizing DMV, de Wit-van der Veen BJ, Verheij M, Stokkel MPM. Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review. Ejnmmi Research. 8: 89. PMID 30159614 DOI: 10.1186/S13550-018-0443-Z |
0.313 |
|
| 2018 |
Cats A, Sikorska K, Verheij M. Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply. The Lancet. Oncology. 19: e331. PMID 30084374 DOI: 10.1016/S1470-2045(18)30436-4 |
0.339 |
|
| 2018 |
Claassen YHM, van Amelsfoort RM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Boot H, Trip AK, Jansen EPM, Kranenbarg EM, Braak JPBM, Putter H, Henegouwen MIVB, ... Verheij M, et al. Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results from the CRITICS Trial. Annals of Surgery. PMID 29995679 DOI: 10.1097/Sla.0000000000002940 |
0.34 |
|
| 2018 |
Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, ... Verheij M, et al. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects and poor outcome in patients with advanced head and neck squamous cell carcinoma. Oncotarget. 9: 18198-18213. PMID 29719599 DOI: 10.18632/Oncotarget.24797 |
0.316 |
|
| 2018 |
Claassen YHM, van Sandick JW, Hartgrink HH, Dikken JL, De Steur WO, van Grieken NCT, Boot H, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, et al. Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial. The British Journal of Surgery. 105: 728-735. PMID 29652082 DOI: 10.1002/Bjs.10773 |
0.336 |
|
| 2018 |
Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, Meershoek-Klein Kranenbarg E, Boot H, Trip AK, Swellengrebel HAM, van Laarhoven HWM, Putter H, van Sandick JW, van Berge Henegouwen MI, Hartgrink HH, ... ... Verheij M, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. The Lancet. Oncology. PMID 29650363 DOI: 10.1016/S1470-2045(18)30132-3 |
0.367 |
|
| 2018 |
Claassen YHM, Hartgrink HH, Dikken JL, de Steur WO, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Meershoek-Klein Kranenbarg WM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 29503129 DOI: 10.1016/J.Ejso.2018.02.004 |
0.369 |
|
| 2018 |
Slotman BJ, Vos P, Slot A, Keus R, Verheij M. Radiation Oncology in The Netherlands. International Journal of Radiation Oncology, Biology, Physics. 100: 5-11. PMID 29254780 DOI: 10.1016/J.Ijrobp.2017.09.005 |
0.303 |
|
| 2018 |
Leal A, Grieken NCTv, Phallen J, Palsgrove DN, Adleff V, Warmerdam F, Peet DLVd, Verheul HMW, Spronsen DJV, Riel JMV, Geenen M, Portielje JEA, Laarhoven HWMV, Jansen EP, Sikorska K, ... ... Verheij M, et al. Circulating tumor DNA dynamics in resectable gastric cancer. Journal of Clinical Oncology. 36: 4069-4069. DOI: 10.1200/Jco.2018.36.15_Suppl.4069 |
0.348 |
|
| 2018 |
Van Amelsfoort R, Walraven I, Jansen EP, Cats A, van Grieken NC, Aaronson NK, Boot H, Lind PA, Meershoek – Klein Kranenbarg E, Nordsmark M, Putter H, Trip AK, van Sandick JW, Sikorska K, van Tinteren H, ... ... Verheij M, et al. Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer. Journal of Clinical Oncology. 36: 4060-4060. DOI: 10.1200/Jco.2018.36.15_Suppl.4060 |
0.347 |
|
| 2018 |
Argenzio E, Moolenaar WH, Verheij M. Abstract 5454: New insights into the mode of action of cytotoxic alkyl-phospholipids Cancer Research. 78: 5454-5454. DOI: 10.1158/1538-7445.Am2018-5454 |
0.326 |
|
| 2018 |
Pelt VWJV, Jansen EPM, Rutten AB, Dieren JMV, Sandick JWV, Grootscholten C, Heide UAVd, Nowee M, Verheij M. EP-1439: MRI-based clinical target volume delineation in gastric cancer: first results of a feasibility study Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31748-1 |
0.323 |
|
| 2018 |
Kwint MH, Walraven I, Marshall MS, Verheij M, Sonke JJ, Belderbos JSA, Janssen TM. EP-1383: The use of Real World Evidence to audit NTCP-models for acute esophagus toxicity in NSCLC patients Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31692-X |
0.459 |
|
| 2018 |
Marin KJO, Lambrecht M, Arends AJ, Adebahr S, Nestle U, Vogel W, Verheij M, Sonke JJ, Hurkmans CW. PO-0977: Assessment of motion and SUV recovery in 3D and 4D PET/CT: a multicentre phantom study Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31287-8 |
0.425 |
|
| 2018 |
Lambrecht M, Sonke JJ, Nestle U, Peulen H, Weber D, Verheij M, Hurkmans CW. PO-0967: Quality assurance of 4DCT in the EORTC Lungtech trial on SBRT for patients with NSCLC Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31277-5 |
0.479 |
|
| 2018 |
Verheij M, Amelsfoort RV, Sikorska K, Jansen E, Cats A, Grieken NV, Boot H, Lind P, Kranenbarg EM, Nordsmark M, Hartgrink H, Putter H, Trip A, Sandick JV, Tinteren HV, et al. OC-0168: Patterns of recurrence in the CRITICS gastric cancer phase III trial Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30478-X |
0.337 |
|
| 2017 |
Kwint M, Walraven I, Burgers S, Hartemink K, Klomp H, Knegjens J, Verheij M, Belderbos J. Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases. Lung Cancer (Amsterdam, Netherlands). 112: 134-139. PMID 29191586 DOI: 10.1016/J.Lungcan.2017.08.006 |
0.333 |
|
| 2017 |
Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 8: 87638-87646. PMID 29152107 DOI: 10.18632/Oncotarget.20936 |
0.413 |
|
| 2017 |
Claassen YHM, de Steur WO, Hartgrink HH, Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen EPM, Kranenbarg WMM, Braak JPBM, Putter H, van Berge Henegouwen MI, Verheij M, van de Velde CJH. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial. Annals of Surgery. PMID 28817437 DOI: 10.1097/Sla.0000000000002444 |
0.314 |
|
| 2017 |
Al-Mamgani A, Verheij M, Brekel MWMvd. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift. European Journal of Cancer. 82: 1-5. PMID 28633075 DOI: 10.1016/J.Ejca.2017.05.035 |
0.347 |
|
| 2017 |
Verkooijen HM, Kerkmeijer LGW, Fuller CD, Huddart R, Faivre-Finn C, Verheij M, Mook S, Sahgal A, Hall E, Schultz C. R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology. Frontiers in Oncology. 7: 59. PMID 28421162 DOI: 10.3389/Fonc.2017.00059 |
0.533 |
|
| 2017 |
Claassen YHM, Steur WOD, Hartgrink HH, Sandick JWV, Dikken JL, Kranenberg EM, Braak J, Jansen EPM, Grieken NCTV, Putter H, Trip A, Boot H, Cats A, Sikorska K, Tinteren HV, ... Verheij M, et al. Surgicopathological quality control in the CRITICS gastric cancer trial European Journal of Cancer. 72. DOI: 10.1016/S0959-8049(17)30104-1 |
0.325 |
|
| 2017 |
Lambrecht M, Marin KO, Fontaine ML, Sonke JJ, Boellaard R, Verheij M, Hurkmans CW. EP-1682: Comparison of SUV based on different ROIs and VOIs definitions: a multi-center 4D phantom study Radiotherapy and Oncology. 123. DOI: 10.1016/S0167-8140(17)32214-4 |
0.427 |
|
| 2017 |
Pelt VWJV, Kruis MF, Lindt TVd, Beek LCT, Verheij M, Heide UAVd. PO-0904: Development of an MRI-protocol for radiotherapy treatment guidance in gastric cancer Radiotherapy and Oncology. 123. DOI: 10.1016/S0167-8140(17)31341-5 |
0.336 |
|
| 2017 |
Lambrecht M, Sonke JJ, Verheij M, Hurkmans CW. OC-0539: A multicentre QA study on 4DCT and IMRT/VMAT techniques for lung SBRT using a respiratory phantom Radiotherapy and Oncology. 123. DOI: 10.1016/S0167-8140(17)30979-9 |
0.437 |
|
| 2017 |
Janssen TM, Dikstaal A, Kwint M, Marshall S, Wolf AL, Knegjens J, Moonen L, Belderbos J, Sonke JJ, Verheij M, Vliet-Vroegindeweij CV. OC-0040: Validation of prospective electronic toxicity registration to audit dose constraints Radiotherapy and Oncology. 123. DOI: 10.1016/S0167-8140(17)30484-X |
0.459 |
|
| 2017 |
Elbers J, Paping D, Verheij M, Brekel Mvd, Boer JPd, Lohuis P, Al-Mamgani A, Zuur L. Poster ViewingDefinitive (Chemo)Radiation Therapy is a Curative Alternative for Standard of Care in Advanced Stage Squamous Cell Carcinoma of the Oral Cavity International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1400 |
0.31 |
|
| 2016 |
Hamming-Vrieze O, van Kranen SR, Heemsbergen WD, Lange CA, van den Brekel MW, Verheij M, Rasch CR, Sonke JJ. Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27866848 DOI: 10.1016/J.Radonc.2016.10.012 |
0.646 |
|
| 2016 |
Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M. The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Frontiers in Oncology. 6: 215. PMID 27790408 DOI: 10.3389/Fonc.2016.00215 |
0.489 |
|
| 2016 |
Mizrachi A, Cotrim AP, Katabi N, Mitchell JB, Verheij M, Haimovitz-Friedman A. Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for Radioprotectors. Radiation Research. PMID 27459704 DOI: 10.1667/Rr14431.1 |
0.34 |
|
| 2016 |
Walraven I, Aaronson N, Sonke JJ, Verheij M, Belderbos J. Adverse event development in clinical oncology trials. The Lancet. Oncology. 17: e263. PMID 27396639 DOI: 10.1016/S1470-2045(16)30197-8 |
0.468 |
|
| 2016 |
Walraven I, van den Heuvel M, van Diessen J, Schaake E, Uyterlinde W, Aerts J, Koppe F, Codrington H, Kunst P, Dieleman E, van de Vaart P, Verheij M, Belderbos J. Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 118: 442-6. PMID 26900091 DOI: 10.1016/J.Radonc.2016.02.011 |
0.373 |
|
| 2016 |
Lambrecht M, Melidis C, Sonke JJ, Adebahr S, Boellaard R, Verheij M, Guckenberger M, Nestle U, Hurkmans C. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective. Radiation Oncology (London, England). 11: 7. PMID 26791788 DOI: 10.1186/S13014-015-0567-5 |
0.517 |
|
| 2016 |
Verheij M, Jansen EP, Cats A, van Grieken NC, Aaronson NK, Boot H, Lind PA, Meershoek – Klein Kranenbarg E, Nordsmark M, Putter H, Trip AK, van Sandick JW, Sikorska K, van Tinteren H, Van De Velde CJH. A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study. Journal of Clinical Oncology. 34: 4000-4000. DOI: 10.1200/Jco.2016.34.15_Suppl.4000 |
0.374 |
|
| 2016 |
Verheij M, Cats A, Edwin PMJ, Nicole CTvG, Neil KA, Boot H, Pehr AL, Kranenbarg EM–K, Nordsmark M, Putter H, Tinteren Hv, Cornelis JHVDV. LBA-02A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: first results from the CRITICS study Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw237.02 |
0.334 |
|
| 2016 |
Janssen T, Wolf AL, Knegjens J, Moonen L, Belderbos J, Sonke JJ, Verheij M, Vliet-Vroegindeweij CV. EP-1716: Prospective electronic toxicity registration to audit NTCP models and dose constraints Radiotherapy and Oncology. 119. DOI: 10.1016/S0167-8140(16)32967-X |
0.459 |
|
| 2016 |
Claassen Y, De Steur W, Dikken J, Hartgrink H, Jansen E, Trip A, Van Grieken N, Putter H, Meershoek – Klein Kranenberg E, Van Sandick J, Boot H, Cats A, Aaronson N, Sikorska K, Van Tinteren H, ... Verheij M, et al. 78. Surgicopathological quality control in the CRITICS gastric cancer trial European Journal of Surgical Oncology (Ejso). 42: S98. DOI: 10.1016/J.Ejso.2016.06.084 |
0.325 |
|
| 2015 |
Widder J, van der Schaaf A, Lambin P, Marijnen CA, Pignol JP, Rasch CR, Slotman BJ, Verheij M, Langendijk JA. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine. International Journal of Radiation Oncology, Biology, Physics. PMID 26684410 DOI: 10.1016/J.Ijrobp.2015.10.004 |
0.563 |
|
| 2015 |
de Jong MC, Ten Hoeve J, Grenman R, Wessels L, Kerkhoven R, Te Riele H, van den Brekel MW, Verheij M, Begg AC. Pretreatment microRNA expression impacting on epithelial to mesenchymal transition predicts intrinsic radiosensitivity in head and neck cancer celllines and patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26265694 DOI: 10.1158/1078-0432.Ccr-15-0454 |
0.303 |
|
| 2015 |
Trip AK, Sikorska K, van Sandick JW, Heeg M, Cats A, Boot H, Jansen EP, Verheij M. Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 239-44. PMID 26253953 DOI: 10.1016/J.Radonc.2015.07.036 |
0.38 |
|
| 2015 |
Zerp SF, Stoter TR, Hoebers FJ, van den Brekel MW, Dubbelman R, Kuipers GK, Lafleur MV, Slotman BJ, Verheij M. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer. Radiation Oncology (London, England). 10: 158. PMID 26223311 DOI: 10.1186/S13014-015-0474-9 |
0.372 |
|
| 2015 |
Cordeiro Pedrosa LR, van Tellingen O, Soullié T, Seynhaeve AL, Eggermont AM, Ten Hagen TL, Verheij M, Koning GA. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 94: 207-19. PMID 25982691 DOI: 10.1016/J.Ejpb.2015.05.003 |
0.307 |
|
| 2015 |
Verhagen CV, de Haan R, Hageman F, Oostendorp TP, Carli AL, O'Connor MJ, Jonkers J, Verheij M, van den Brekel MW, Vens C. Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 25981132 DOI: 10.1016/J.Radonc.2015.03.028 |
0.342 |
|
| 2015 |
Hodzic J, Dingjan I, Maas MJ, van der Meulen-Muileman IH, de Menezes RX, Heukelom S, Verheij M, Gerritsen WR, Geldof AA, van Triest B, van Beusechem VW. A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting. Radiation Oncology (London, England). 10: 55. PMID 25888875 DOI: 10.1186/S13014-015-0355-2 |
0.343 |
|
| 2015 |
Trip AK, Stiekema J, Visser O, Dikken JL, Cats A, Boot H, van Sandick JW, Jansen EP, Verheij M. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study. Acta Oncologica (Stockholm, Sweden). 54: 1754-62. PMID 25797568 DOI: 10.3109/0284186X.2015.1009638 |
0.333 |
|
| 2015 |
Heukelom J, Lopez-Yurda M, Balm AJ, Wijers OB, Buter J, Gregor T, Wiggenraad R, de Boer JP, Tan IB, Verheij M, Sonke JJ, Rasch CR. Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer. Head & Neck. PMID 25728984 DOI: 10.1002/Hed.24023 |
0.779 |
|
| 2015 |
Chen W, Sonke JJ, Stroom J, Bartelink H, Verheij M, Gilhuijs K. The effect of age in breast conserving therapy: a retrospective analysis on pathology and clinical outcome data. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 114: 314-21. PMID 25640300 DOI: 10.1016/J.Radonc.2015.01.010 |
0.457 |
|
| 2015 |
van den Heuvel MM, Verheij M, Boshuizen R, Belderbos J, Dingemans AM, De Ruysscher D, Laurent J, Tighe R, Haanen J, Quaratino S. NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy. Journal of Translational Medicine. 13: 32. PMID 25622640 DOI: 10.1186/S12967-015-0397-0 |
0.303 |
|
| 2015 |
Pedrosa LR, Ten Hagen TL, Süss R, van Hell A, Eggermont AM, Verheij M, Koning GA. Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells. Pharmaceutical Research. 32: 1354-67. PMID 25319103 DOI: 10.1007/S11095-014-1539-4 |
0.311 |
|
| 2015 |
Stiekema J, Trip AK, Jansen EP, Aarts MJ, Boot H, Cats A, Ponz OB, Gradowska PL, Verheij M, van Sandick JW. Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study. Annals of Surgical Oncology. 22: 581-8. PMID 25164039 DOI: 10.1245/S10434-014-4032-8 |
0.334 |
|
| 2015 |
Zerp S, Stoter TR, Hoebers FJP, Brekel MWMVd, Dubbelman R, Kuipers G, Lafleur V, Slotman BJ, Verheij M. PO-1060: Combining radiation with the pan-Bcl-2 inhibitor AT-101: in vitro studies and clinical pharmacokinetics in HNSCC Radiotherapy and Oncology. 115. DOI: 10.1016/S0167-8140(15)41052-7 |
0.331 |
|
| 2015 |
Hamming-Vrieze O, Depauw N, Craft DL, Chan AW, Verheij M, Sonke JJ, Kooy H. PO-0791: Interpretation of uncertainty scenarios for head and neck IMPT treatment plans using TCP and NTCP models Radiotherapy and Oncology. 115. DOI: 10.1016/S0167-8140(15)40783-2 |
0.467 |
|
| 2015 |
Trip AK, Sikorska K, Boot H, Cats A, Sandick JWV, Jansen EPM, Verheij M. PO-0694: Radiation dose-dependent changes of the spleen following chemoradiotherapy for gastric cancer Radiotherapy and Oncology. 115. DOI: 10.1016/S0167-8140(15)40686-3 |
0.366 |
|
| 2014 |
Trip AK, Nijkamp J, van Tinteren H, Cats A, Boot H, Jansen EP, Verheij M. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 112: 289-94. PMID 25241995 DOI: 10.1016/J.Radonc.2014.08.039 |
0.336 |
|
| 2014 |
Verbrugge I, Gasparini A, Haynes NM, Hagekyriakou J, Galli M, Stewart TJ, Abrams SI, Yagita H, Verheij M, Johnstone RW, Borst J, Neefjes J. The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling. Radiation Research. 182: 219-29. PMID 24960417 DOI: 10.1667/Rr13511.1 |
0.332 |
|
| 2014 |
Trip AK, Poppema BJ, van Berge Henegouwen MI, Siemerink E, Beukema JC, Verheij M, Plukker JT, Richel DJ, Hulshof MC, van Sandick JW, Cats A, Jansen EP, Hospers GA. Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 112: 284-8. PMID 24856116 DOI: 10.1016/J.Radonc.2014.05.003 |
0.353 |
|
| 2014 |
Verheij M, Moolenaar WH, Van Blitterswijk WJ. Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: Rationale and clinical outlook Anti-Cancer Agents in Medicinal Chemistry. 14: 618-628. PMID 24628238 DOI: 10.2174/1871520614666140309224145 |
0.357 |
|
| 2014 |
Zerp SF, Vens C, Floot B, Verheij M, van Triest B. NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 348-54. PMID 24412016 DOI: 10.1016/J.Radonc.2013.10.039 |
0.358 |
|
| 2014 |
Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. International Journal of Radiation Oncology, Biology, Physics. 88: 624-9. PMID 24411620 DOI: 10.1016/J.Ijrobp.2013.11.213 |
0.354 |
|
| 2014 |
Stiekema J, Trip AK, Jansen EP, Boot H, Cats A, Ponz OB, Verheij M, van Sandick JW. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy. Annals of Surgical Oncology. 21: 1107-14. PMID 24306660 DOI: 10.1245/S10434-013-3397-4 |
0.334 |
|
| 2014 |
van den Heuvel MM, Uyterlinde W, Vincent AD, de Jong J, Aerts J, Koppe F, Knegjens J, Codrington H, Kunst PW, Dieleman E, Verheij M, Belderbos J. Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 126-31. PMID 24225233 DOI: 10.1016/J.Radonc.2013.10.009 |
0.359 |
|
| 2014 |
Rottenberg S, Borst G, Gasparini A, Barazas M, Guyader C, Sol W, Kersbergen A, Verheij M, Sonke JJ. 169: Homologous recombination deficiency and radio-curability in mouse models for BRCA1/2-deficient breast cancer Radiotherapy and Oncology. 110. DOI: 10.1016/S0167-8140(15)34190-6 |
0.456 |
|
| 2014 |
Borst G, Coackley C, Yucel H, Guyader C, Berlin A, Sonke J, Verheij M, Jonkers J, Rottenberg S, Bristow R. OC-0487: Genetically engineered breast cancer mouse models to explore and target radioresistance Radiotherapy and Oncology. 111: S190. DOI: 10.1016/S0167-8140(15)30592-2 |
0.458 |
|
| 2014 |
Berlo DV, Gasparini A, Verheij M, Sonke JJ, Vens C. OC-0051: Towards the clinic: application of μ-IGRT for assessment of radiationinduced pneumonitis and pulmonary fibrosis Radiotherapy and Oncology. 111. DOI: 10.1016/S0167-8140(15)30156-0 |
0.42 |
|
| 2014 |
Borst G, Barazas M, Gasparini A, Sol W, Jonkers J, Verheij M, Sonke J, Rottenberg S. Genetically Enigineered Mouse Models and High Precision Fractionated Radiation Therapy to Unravel Mechanisms of Irradiation Escape International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2253 |
0.477 |
|
| 2013 |
Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 267-73. PMID 23759662 DOI: 10.1016/J.Radonc.2013.05.007 |
0.342 |
|
| 2013 |
Stiekema J, Cats A, Kuijpers A, van Coevorden F, Boot H, Jansen EP, Verheij M, Balague Ponz O, Hauptmann M, van Sandick JW. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 39: 686-93. PMID 23498364 DOI: 10.1016/J.Ejso.2013.02.026 |
0.319 |
|
| 2013 |
Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. Bmc Cancer. 13: 84. PMID 23433435 DOI: 10.1186/1471-2407-13-84 |
0.792 |
|
| 2013 |
Dikken JL, Baser RE, Gonen M, Kattan MW, Shah MA, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of Surgical Oncology. 20: 1623-30. PMID 23143591 DOI: 10.1245/S10434-012-2723-6 |
0.323 |
|
| 2013 |
van Blitterswijk WJ, Verheij M. Anticancer mechanisms and clinical application of alkylphospholipids. Biochimica Et Biophysica Acta. 1831: 663-74. PMID 23137567 DOI: 10.1016/J.Bbalip.2012.10.008 |
0.302 |
|
| 2013 |
Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, van Sandick JW. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Annals of Surgical Oncology. 20: 381-98. PMID 23054104 DOI: 10.1245/S10434-012-2574-1 |
0.327 |
|
| 2013 |
Borst GR, McLaughlin M, Kyula JN, Neijenhuis S, Khan A, Good J, Zaidi S, Powell NG, Meier P, Collins I, Garrett MD, Verheij M, Harrington KJ. Targeted radiosensitization by the Chk1 inhibitor SAR-020106. International Journal of Radiation Oncology, Biology, Physics. 85: 1110-8. PMID 22981708 DOI: 10.1016/J.Ijrobp.2012.08.006 |
0.328 |
|
| 2013 |
Dikken JL, Cats A, Verheij M, van de Velde CJ. Randomized trials and quality assurance in gastric cancer surgery. Journal of Surgical Oncology. 107: 298-305. PMID 22488766 DOI: 10.1002/Jso.23080 |
0.356 |
|
| 2013 |
Trip AK, Poppema BJ, Henegouwen MIvB, Jansen EP, Siemerink E, Richel D, Beukema JC, Plukker JT, Sandick JWv, Hulshof MC, Cats A, Verheij M, Hospers G. Preoperative chemoradiotherapy (CRT) in gastric cancer. Journal of Clinical Oncology. 31: 89-89. DOI: 10.1200/Jco.2013.31.4_Suppl.89 |
0.386 |
|
| 2013 |
Hodzic J, Meulen Ivd, Menezes Rd, Dingjan I, Maas MJ, Gerritsen W, Verheij M, Geldof AA, Triest Bv, Beusechem VWv. Abstract 4434: Identification of radiation susceptibility genes in prostate cancer by whole genome RNA interference screening. Cancer Research. 73: 4434-4434. DOI: 10.1158/1538-7445.Am2013-4434 |
0.351 |
|
| 2013 |
Hell AJv, Melo M, Blitterswijk Wv, Dijkema T, Pedrosa L, Koning G, Marrink SJ, Jonkers J, Verheij M. Abstract 3382: Formation of transient membrane channels targets doxorubicin resistance. Cancer Research. 73: 3382-3382. DOI: 10.1158/1538-7445.Am2013-3382 |
0.311 |
|
| 2013 |
Borst GR, Gasparini A, Sol W, Kersbergen A, Jonkers J, Verheij M, Sonke JJ, Rottenberg S. PO-0758: Modelling radiotherapy escape using BRCA1/2-def mouse mammary tumors and image-guided irradiation Radiotherapy and Oncology. 106. DOI: 10.1016/S0167-8140(15)33064-4 |
0.47 |
|
| 2013 |
Heukelom J, Nichol K, Bartelink H, Hamming O, Lamers E, Rasch C, Verheij M, Sonke J. PO-0662: Planning according to plan: quality assurance in a randomized international multicenter phase II trial Radiotherapy and Oncology. 106: S254-S255. DOI: 10.1016/S0167-8140(15)32968-6 |
0.749 |
|
| 2013 |
Borst G, Gasparini A, Sol W, Kersbergen A, Jonkers J, Verheij M, Sonke J, Rottenberg S. Using BRCA1/2-Deficient Mouse Mammary Tumors and μIGRT to Investigate Underlying Mechanisms Causing Radioresistance International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.058 |
0.434 |
|
| 2012 |
Jansen EP, Boot H, van de Velde CJ, van Sandick J, Cats A, Verheij M. Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer? Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 196: 229-40. PMID 23129378 DOI: 10.1007/978-3-642-31629-6_16 |
0.352 |
|
| 2012 |
Haimovitz-Friedman A, Yang TJ, Thin TH, Verheij M. Imaging radiotherapy-induced apoptosis. Radiation Research. 177: 467-82. PMID 22348249 DOI: 10.1667/Rr2576.1 |
0.329 |
|
| 2012 |
Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, van Sandick JW, Cats A, Verheij M, Coebergh JW, van de Velde CJ. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. European Journal of Cancer (Oxford, England : 1990). 48: 1624-32. PMID 22317953 DOI: 10.1016/J.Ejca.2012.01.009 |
0.331 |
|
| 2012 |
Dikken JL, Velde CJHvd, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer Therapeutic Advances in Gastroenterology. 5: 49-69. PMID 22282708 DOI: 10.1177/1756283X11410771 |
0.38 |
|
| 2012 |
Dikken JL, van Grieken NC, Krijnen P, Gönen M, Tang LH, Cats A, Verheij M, Brennan MF, van de Velde CJ, Coit DG. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38: 319-25. PMID 22261085 DOI: 10.1016/J.Ejso.2011.12.016 |
0.35 |
|
| 2012 |
Heuvel MMvd, Vincent AD, Uyterlinde W, Aerts J, Koppe F, Codrington H, Kunst PWE, Dieleman E, Vaart Pvd, Verheij M, Belderbos J. A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy. Journal of Clinical Oncology. 30: 7019-7019. DOI: 10.1200/Jco.2012.30.15_Suppl.7019 |
0.355 |
|
| 2012 |
Zerp S, Triest BV, Floot B, Vens C, Verheij M. Abstract C31: NAMPT inhibition combined with radiation enhances cell death in a prostate cancer model Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-C31 |
0.377 |
|
| 2012 |
Hell AJv, Koning G, Jonkers J, Verheij M. Abstract 2761: Co-administration of the short-chain sphingolipid N-octanoyl-glucosylceramide improves doxorubicin therapy by enhancing intracellular drug accumulation in vivo Cancer Research. 72: 2761-2761. DOI: 10.1158/1538-7445.Am2012-2761 |
0.302 |
|
| 2012 |
Triest BV, Zerp SF, Floot B, Vens C, Verheij M. Abstract 1462: Targeting NAD+biosynthesis combined with radiation to enhance cell death Cancer Research. 72: 1462-1462. DOI: 10.1158/1538-7445.Am2012-1462 |
0.375 |
|
| 2012 |
Zerp SF, Vens C, Floot B, Verheij M, Triest Bv. P0-42: Targeting NAD+ Biosynthesis Combined with Radiation to Enhance Cell Death Radiotherapy and Oncology. 104: 34. DOI: 10.1016/S0167-8140(15)34596-5 |
0.302 |
|
| 2012 |
Trip AK, Nijkamp J, Cats A, Boot H, Verheij M, Jansen EPM. Oc-0475 The Use Of Imrt Reduces Late Nephrotoxicity After Chemoradiotherapy For Gastric Cancer Radiotherapy and Oncology. 103. DOI: 10.1016/S0167-8140(12)70814-9 |
0.32 |
|
| 2012 |
Verheij M, Zerp S, Floot B, Vens C, Triest BV. Oc-0068 The Nad+ Depleting Agent Apo866 Enhances Cell Death When Combined With Radiation Radiotherapy and Oncology. 103. DOI: 10.1016/S0167-8140(12)70407-3 |
0.32 |
|
| 2012 |
Stiekema J, Dikken JL, Velde CJHvd, Verheij M, Cats A, Wouters MWJM, Sandick JWv. 101. Quality of care indicators for the surgical treatment of gastric cancer Ejso. 38: 764. DOI: 10.1016/J.Ejso.2012.06.101 |
0.309 |
|
| 2011 |
Dikken JL, Van De Velde CJ, Verheij M, Baser R, Gonen M, Kattan MW, Shah MA, Brennan MF, Coit DG. Conditional survival nomogram after an R0 resection for gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 11. PMID 27985750 DOI: 10.1200/Jco.2011.29.4_Suppl.11 |
0.329 |
|
| 2011 |
Dikken JL, Krijnen P, Van De Velde CJ, Verheij M, Gonen M, van Grieken NC, Tang LH, Brennan MF, Coit DG. The effect of preoperative chemotherapy on lymph node yield in gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 80. PMID 27985593 DOI: 10.1200/Jco.2011.29.4_Suppl.80 |
0.32 |
|
| 2011 |
Dikken JL, Verheij M, Cats A, Jansen EPM, Hartgrink HH, Velde CJHvd. Extended lymph node dissection for gastric cancer from a European perspective Gastric Cancer. 14: 396-398. PMID 21837457 DOI: 10.1007/S10120-011-0081-X |
0.361 |
|
| 2011 |
Dikken JL, Sandick JWv, Swellengrebel HAM, Lind PA, Putter H, Jansen EPM, Boot H, Grieken NCTv, Velde CJHvd, Verheij M, Cats A. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) Bmc Cancer. 11: 329-329. PMID 21810227 DOI: 10.1186/1471-2407-11-329 |
0.382 |
|
| 2011 |
Beekman CA, Buckle T, van Leeuwen AC, Valdés Olmos RA, Verheij M, Rottenberg S, van Leeuwen FW. Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 69: 656-62. PMID 21227707 DOI: 10.1016/J.Apradiso.2010.12.012 |
0.308 |
|
| 2011 |
van Lummel M, van Blitterswijk WJ, Vink SR, Veldman RJ, van der Valk MA, Schipper D, Dicheva BM, Eggermont AM, ten Hagen TL, Verheij M, Koning GA. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 280-9. PMID 20876209 DOI: 10.1096/Fj.10-163709 |
0.308 |
|
| 2011 |
Hell AJv, Koning G, Jonkers J, Blitterswijk Wv, Verheij M. Abstract 4438: A membrane modulating strategy improves doxorubicin therapy in spontaneous mouse breast carcinoma Cancer Research. 71: 4438-4438. DOI: 10.1158/1538-7445.Am2011-4438 |
0.36 |
|
| 2011 |
Verheij M, Dikken J, Jansen E, Hartgrink H, Putter H, Boot H, Cats A, Velde Cvd. 165 oral POSTOPERATIVE CHEMORADIOTHERAPY IMPROVES SURVIVAL AFTER D1 LYMPHADENECTOMY OR R1 RESECTION IN GASTRIC CANCER Radiotherapy and Oncology. 99. DOI: 10.1016/S0167-8140(11)70287-0 |
0.311 |
|
| 2010 |
Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Annals of Oncology. 27. PMID 20555102 DOI: 10.1093/Annonc/Mdq164 |
0.314 |
|
| 2010 |
Dikken JL, Jansen EPM, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KCMJ, Velde CJHvd, Verheij M. Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer Journal of Clinical Oncology. 28: 2430-2436. PMID 20368551 DOI: 10.1200/Jco.2009.26.9654 |
0.337 |
|
| 2010 |
Verheij M, Vens C, Triest Bv. Novel therapeutics in combination with radiotherapy to improve cancer treatment: rationale, mechanisms of action and clinical perspective. Drug Resistance Updates. 13: 29-43. PMID 20167530 DOI: 10.1016/J.Drup.2010.01.002 |
0.36 |
|
| 2010 |
Jansen EPM, Nijkamp J, Gubanski M, Lind PARM, Verheij M. Interobserver variation of clinical target volume delineation in gastric cancer. International Journal of Radiation Oncology Biology Physics. 77: 1166-1170. PMID 19836158 DOI: 10.1016/J.Ijrobp.2009.06.023 |
0.315 |
|
| 2010 |
Verbrugge I, Maas C, Heijkoop M, Verheij M, Borst J. Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Cell Death and Differentiation. 17: 551-61. PMID 19798106 DOI: 10.1038/Cdd.2009.141 |
0.313 |
|
| 2010 |
Jansen EPM, Boot H, Dubbelman R, Verheij M, Cats A. Postoperative chemoradiotherapy in gastric cancer––a phase I–II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy Annals of Oncology. 21: 530-534. PMID 19690058 DOI: 10.1093/Annonc/Mdp345 |
0.37 |
|
| 2010 |
Dikken JL, Jansen EPM, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KCMJ, Velde CJHvd, Verheij M. Reply to F. Sclafani et al Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.31.1746 |
0.361 |
|
| 2010 |
Hell AJv, Lummel Mv, Koning GA, Blitterswijk WJv, Verheij M. Abstract 5527: Short-chain glucosylceramide improves doxorubicin delivery in spontaneous mouse breast carcinomas Cancer Research. 70: 5527-5527. DOI: 10.1158/1538-7445.Am10-5527 |
0.327 |
|
| 2010 |
Verheij M, Dikken J, Jansen E, Hartgrink H, Putter H, Boot H, Cats A, Velde Cvd. Postoperative Chemoradiotherapy Improves Survival after D1 Lymphadenectomy or R1 Resection in Gastric Cancer International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.204 |
0.308 |
|
| 2009 |
Verbrugge I, Wissink EH, Rooswinkel RW, Jongsma J, Beltraminelli N, Dupuis M, Borst J, Verheij M. Combining radiotherapy with APO010 in cancer treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2031-8. PMID 19276268 DOI: 10.1158/1078-0432.Ccr-08-2125 |
0.367 |
|
| 2009 |
Heuvel MMvd, Belderbos J, Dalesio O, Pol Mvd, Uitterhoeve L, Vaart Pvd, Verheij M, Zandwijk Nv. Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study Journal of Clinical Oncology. 27: 7540-7540. DOI: 10.1200/Jco.2009.27.15_Suppl.7540 |
0.334 |
|
| 2009 |
Dikken J, Bakker B, Hartgrink H, Jansen E, Putter H, Boot H, Cats A, Velde Cvd, Verheij M. Patterns of Recurrence after Postoperative Chemoradiotherapy in Gastric Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.152 |
0.31 |
|
| 2009 |
Rasch C, Belderbos J, van Giersbergen A, De Kok I, Laura T, Boer M, de Boer P, Gilles R, Teertstra J, Verheij M. The Influence of a Multi-disciplinary Meeting for Quality Assurance on Target Delineation in Radiotherapy Treatment Preparation International Journal of Radiation Oncology*Biology*Physics. 75: S452-S453. DOI: 10.1016/J.Ijrobp.2009.07.1035 |
0.551 |
|
| 2008 |
Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death Cancer and Metastasis Reviews. 27: 471-480. PMID 18470482 DOI: 10.1007/S10555-008-9131-1 |
0.317 |
|
| 2008 |
Kartachova MS, Olmos RAV, Haas RLM, Hoebers FJP, Herk Mv, Verheij M. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nuclear Medicine Communications. 29: 39-44. PMID 18049096 DOI: 10.1097/Mnm.0B013E3282F1Bc22 |
0.301 |
|
| 2008 |
Hoebers FJ, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H, van Herk M, Rasch CR, Valdés Olmos RA, Verheij M. 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 35: 509-18. PMID 17994297 DOI: 10.1007/S00259-007-0624-X |
0.581 |
|
| 2007 |
Jansen EPM, Boot H, Dubbelman R, Bartelink H, Cats A, Verheij M. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. British Journal of Cancer. 97: 712-716. PMID 17848909 DOI: 10.1038/Sj.Bjc.6603965 |
0.356 |
|
| 2007 |
Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, Verheij M, Cats A. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. International Journal of Radiation Oncology, Biology, Physics. 69: 1424-8. PMID 17689023 DOI: 10.1016/J.Ijrobp.2007.05.004 |
0.385 |
|
| 2007 |
Hoebers FJ, Pluim D, Hart AA, Verheij M, Balm AJ, Fons G, Rasch CR, Schellens JH, Stalpers LJ, Bartelink H, Begg AC. Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor. Cancer Chemotherapy and Pharmacology. 61: 1075-81. PMID 17639394 DOI: 10.1007/S00280-007-0545-1 |
0.564 |
|
| 2007 |
Kartachova M, Zandwijk Nv, Burgers S, Tinteren Hv, Verheij M, Olmos RAV. Prognostic Significance of 99mTc Hynic-rh-Annexin V Scintigraphy During Platinum-Based Chemotherapy in Advanced Lung Cancer Journal of Clinical Oncology. 25: 2534-2539. PMID 17577031 DOI: 10.1200/Jco.2006.10.1337 |
0.374 |
|
| 2007 |
Knoops L, Haas R, Kemp Sd, Majoor D, Broeks A, Eldering E, Boer JPd, Verheij M, Ostrom Cv, Vries Ad, Veer Lv, Jong Dd. In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma Blood. 110: 1116-1122. PMID 17483295 DOI: 10.1182/Blood-2007-01-067579 |
0.322 |
|
| 2007 |
Vink SR, van Blitterswijk WJ, Schellens JH, Verheij M. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treatment Reviews. 33: 191-202. PMID 17287087 DOI: 10.1016/J.Ctrv.2006.12.001 |
0.371 |
|
| 2007 |
Jansen EPM, Saunders MP, Boot H, Oppedijk V, Dubbelman R, Porritt B, Cats A, Stroom J, Olmos RV, Bartelink H, Verheij M. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. International Journal of Radiation Oncology Biology Physics. 67: 781-785. PMID 17157445 DOI: 10.1016/J.Ijrobp.2006.09.012 |
0.314 |
|
| 2007 |
Hoebers F, Kartachova M, Brekel Mvd, Bois Jd, Herk Mv, Rasch C, Olmos RV, Verheij M. 99MTC hynic-RH-annexin V scintigraphy for in vivo imaging of apoptosis in patients with advanced head and neck cancer treated with concurrent cisplatin and radiotherapy Radiotherapy and Oncology. 82. DOI: 10.1016/S0167-8140(07)80101-0 |
0.363 |
|
| 2006 |
Dulk Md, Verheij M, Cats A, Jansen EPM, Hartgrink HH, Velde CJHvd. The essentials of locoregional control in the treatment of gastric cancer. Scandinavian Journal of Surgery. 95: 236-242. PMID 17249271 DOI: 10.1177/145749690609500405 |
0.377 |
|
| 2006 |
Wissink EH, Verbrugge I, Vink SR, Schader MB, Schaefer U, Walczak H, Borst J, Verheij M. TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 80: 214-22. PMID 16916556 DOI: 10.1016/J.Radonc.2006.07.030 |
0.301 |
|
| 2006 |
Vink SR, Schellens JH, Beijnen JH, Sindermann H, Engel J, Dubbelman R, Moppi G, Hillebrand MJ, Bartelink H, Verheij M. Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 80: 207-13. PMID 16914220 DOI: 10.1016/J.Radonc.2006.07.032 |
0.381 |
|
| 2006 |
Hoebers FJP, Pluim D, Verheij M, Balm AJM, Bartelink H, Schellens JHM, Begg AC. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT) International Journal of Cancer. 119: 750-756. PMID 16550603 DOI: 10.1002/Ijc.21919 |
0.363 |
|
| 2006 |
Vink SR, Lagerwerf S, Mesman E, Schellens JH, Begg AC, van Blitterswijk WJ, Verheij M. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1615-22. PMID 16533789 DOI: 10.1158/1078-0432.Ccr-05-2033 |
0.375 |
|
| 2006 |
Horsman MR, Bohm L, Margison GP, Milas L, Rosier JF, Safrany G, Selzer E, Verheij M, Hendry JH. Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. International Journal of Radiation Oncology Biology Physics. 64: 551-561. PMID 16414371 DOI: 10.1016/J.Ijrobp.2005.09.032 |
0.332 |
|
| 2006 |
Boot H, Jansen E, Cats A, Dubbelman R, Saunders M, Khoo V, Crosby T, Bartelink H, Verheij M. Postoperative chemoradiotherapy in gastric cancer: results of two parallel phase I???II studies of a fixed radiotherapy regimen with escalating doses of cisplatin and capecitabine European Journal of Gastroenterology & Hepatology. 18. DOI: 10.1097/00042737-200601000-00160 |
0.371 |
|
| 2006 |
Geldof A, Kuipers G, Sminia P, Lafleur M, Zerp S, Yangs D, Lippmann M, Slotman B, Verheij M. 234 Gossypol, a small molecule inhibitor of BCL-2, increases radiation-induced cytotoxicity in human prostate and head and neck cancer cells Radiotherapy and Oncology. 78. DOI: 10.1016/S0167-8140(06)80711-5 |
0.332 |
|
| 2005 |
Vink SR, Schellens JH, van Blitterswijk WJ, Verheij M. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid. Investigational New Drugs. 23: 279-86. PMID 16012787 DOI: 10.1007/S10637-005-1436-0 |
0.328 |
|
| 2005 |
Jansen EPM, Boot H, Verheij M, Velde CJHvd. Optimal Locoregional Treatment in Gastric Cancer Journal of Clinical Oncology. 23: 4509-4517. PMID 16002841 DOI: 10.1200/Jco.2005.21.196 |
0.363 |
|
| 2005 |
Kartachova MS, Verheij M, Hoefnagel CA, Eck BLv, Olmos RAV. Methodological aspects and applications of in vivo imaging of apoptosis in oncology: An illustrative review Current Medical Imaging Reviews. 1: 221-228. DOI: 10.2174/157340505774574736 |
0.333 |
|
| 2005 |
Hoebers F, Pluim D, Balm A, Bartelink H, Begg A, Schellens J, Verheij M. Prediction of Outcome by Cisplatin DNA-adduct Formation in Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma, Treated by Concurrent Cisplatin-Chemoradiation (RADPLAT) International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.607 |
0.347 |
|
| 2005 |
Jansen E, Boot H, Cats A, Dubbelman R, Saunders M, Khoo V, Crosby T, Bartelink H, Verheij M. Postoperative Chemoradiotherapy in Gastric Cancer - Results of Two Parallel Phase I-II Studies of a Fixed Radiotherapy Regimen with Escalating Doses of Cisplatin and Capecitabine International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.475 |
0.371 |
|
| 2004 |
Haas RLM, Jong Dd, Olmos RAV, Hoefnagel CA, Heuvel IvD, Zerp SF, Bartelink H, Verheij M. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients International Journal of Radiation Oncology Biology Physics. 59: 782-787. PMID 15183481 DOI: 10.1016/J.Ijrobp.2003.11.017 |
0.346 |
|
| 2004 |
Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. International Journal of Radiation Oncology Biology Physics. 58: 542-554. PMID 14751526 DOI: 10.1016/J.Ijrobp.2003.09.067 |
0.356 |
|
| 2004 |
Verheij M, Vink SR, Schellens JHM, Beijnen JH, Sindermann H, Engel J, Dubbelman R, Moppi G, Hillebrand MJX, Bartelink H. Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors Journal of Clinical Oncology. 22: 3064-3064. DOI: 10.1200/Jco.2004.22.14_Suppl.3064 |
0.345 |
|
| 2003 |
Haas RLM, Valdés-Olmos RA, Jong Dd, Zerp SF, Heuvel Ivd, Hoefnagel CA, Bartelink H, Verheij M. 710 In vivo assessment of radiation induced apoptosis in follicular lymphoma patients by 99mTc-Annexin V scintigraphy Ejc Supplements. 1. DOI: 10.1016/S1359-6349(03)90741-5 |
0.318 |
|
| 2003 |
Hoebers FJP, Pluim D, Bartelink H, Balm AJM, Begg AC, Rasch CRN, Schellens JHM, Verheij M. 109 Cisplatin-DNA adduct measurements in head and neck cancer patients treated by chemoradiotherapy Ejc Supplements. 1. DOI: 10.1016/S1359-6349(03)90142-X |
0.326 |
|
| 2002 |
Bartelink H, Schellens JHM, Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. European Journal of Cancer. 38: 216-222. PMID 11803138 DOI: 10.1016/S0959-8049(01)00363-X |
0.408 |
|
| 2001 |
Stewart FA, Poele JAMT, Wal AFVd, Oussoren YG, Kleef EMV, Kuin A, Verheij M, Dewit LGH. Radiation nephropathy--the link between functional damage and vascular mediated inflammatory and thrombotic changes. Acta Oncologica. 40: 952-957. PMID 11845960 DOI: 10.1080/02841860152708233 |
0.308 |
|
| 2001 |
Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. International Journal of Radiation Oncology, Biology, Physics. 49: 1305-10. PMID 11286838 DOI: 10.1016/S0360-3016(00)01503-0 |
0.324 |
|
| 2001 |
Ruiter GA, Verheij M, Zerp SF, van Blitterswijk WJ. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. International Journal of Radiation Oncology, Biology, Physics. 49: 415-9. PMID 11173135 DOI: 10.1016/S0360-3016(00)01476-0 |
0.319 |
|
| 2001 |
Schornagel JH, Verheij M, Bartelink H. Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice? Current Oncology Reports. 3: 1-2. PMID 11123863 DOI: 10.1007/S11912-001-0034-3 |
0.391 |
|
| 2000 |
Verheij M, Bartelink H. Radiation-induced apoptosis. Cell and Tissue Research. 301: 133-142. PMID 10928286 DOI: 10.1007/S004410000188 |
0.305 |
|
| 1999 |
Bartelink H, Begg A, Martin JC, Dijk Mv, Veer Lv’, Vaart Pvd, Verheij M. Towards prediction and modulation of treatment response. Radiotherapy and Oncology. 50: 1-11. PMID 10225551 DOI: 10.1016/S0167-8140(99)00009-2 |
0.391 |
|
| 1999 |
Moonen L, Gallee M, Verheij M, Ong F, Horenblas S, Hart A, Bartelink H. 1001 Apoptosis, proliferation and P53, cyclin D1 and retinoblastoma gene expression in relation to radiation response in muscle-invasive bladder cancer International Journal of Radiation Oncology Biology Physics. 45: 257-258. DOI: 10.1016/S0360-3016(99)90227-4 |
0.303 |
|
| 1994 |
Verheij M, Dewit LGH, Olmos RAV, Arisz L. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. International Journal of Radiation Oncology Biology Physics. 30: 677-683. PMID 7928500 DOI: 10.1016/0360-3016(92)90955-H |
0.302 |
|
| 1994 |
Verheij M, Koomen GCM, Mourik JAv, Dewit L. Radiation reduces cyclooxygenase activity in cultured human endothelial cells at low doses. Prostaglandins. 48: 351-366. PMID 7892507 DOI: 10.1016/0090-6980(94)90002-7 |
0.318 |
|
| Show low-probability matches. |